期刊文献+

替诺福韦艾拉酚胺的合成 被引量:4

Synthesis of Tenofovir Alafenamide Fumarate
下载PDF
导出
摘要 初步总结设计了一条替诺福韦艾拉酚胺的合成工艺路线,以R-环氧丙烷与腺嘌呤为起始原料,得到R-9-(2-羟基丙基)腺嘌呤(HPA),再经与对甲苯磺酰氧甲基苄基苯基膦酸酯、丙氨酸异丙酯反应得到替诺福韦艾拉酚胺(TAF)。该方法采用廉价的R-环氧丙烷替代价格昂贵的R-碳酸丙烯酯,使得工艺更为廉价、简洁。 We initially designed a route to synthesize of tenofovir alafenolide, where using Rpropylene oxide and adenine as starting materials to obtain R-9-(2-hydroxypropyl) adenine(HPA), then reacted with p-toluenesulfonyl oxymethyl benzyl phenyl phosphonate and alanine isopropyl ester successively to get tenofovir alafenamide(TAF). This method used inexpensive R-propylene oxide instead of the expensive R-propylene carbonate to make the process cheaper and simpler.
作者 薛金辉 刘景 柯永新 XUE Jin-hui, LIU Jin, KE Yong-xin(College of Pharmaceutic al Sciences, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, Chin)
出处 《浙江化工》 CAS 2018年第4期16-19,共4页 Zhejiang Chemical Industry
关键词 R-环氧丙烷 替诺福韦艾拉酚胺 腺嘌呤 R-propylene oxide tenofovir alafenamide adenine
  • 相关文献

参考文献4

二级参考文献61

  • 1Yu H, Kalyan D, Ding JP, et al. Structures of tyr188leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097:inhibitor flexibility is a useful design feature for reducing drug resistance [J]. J Mol Biol, 199 被引量:1
  • 2Parreira RLT, Abrahao O, et al. Conformational preferences of non-nucleoside HIV-1 reverse transcriptase inhibitors [ J ]. Tetrahedron, 2001,57:3243 - 3253. 被引量:1
  • 3Barreca ML, Carotti A, Carrieri A, et al. Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) [ J]. Bioorg Med Chem, 1999,7:2283 -2292. 被引量:1
  • 4Kalyan D, Ding JP, Yu H, et al. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the tyr181cys HIV-1 RT drug-resistant mutant [J]. J Mol Biol, 1996,264:1085- 1100. 被引量:1
  • 5Gonzales M J, Wu TD, Taylor J, et al. Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors [J]. AIDS, 2003,17(6):791 -799. 被引量:1
  • 6Wang DP, Rizzo RC, Julian TR, et al. Antiviral drug desigh: computational analyses of the effects of the L100I mutation for HIV-RT on the binding of NNRTIs [ J ].Bioorg Med Chem Lett, 2001,11:2799 -2802. 被引量:1
  • 7Ludovici DW, Kukla M J, Grous PG, et al. Evolution of anti-HIV drug candidates. part 1: from otanilinophenylacetamide (αt-APA) to imidoyl thiourea (ITU) [ J ]. Bioorg Med Chem Lett, 2001,11: 2225 -2228. 被引量:1
  • 8Ludovici DW, Kavash RW, Kukla M J, et al. Evolution of anti-HIV drug candidates. part 2: diaryltriazine (DATA) analogues [J]. Bioorg Med Chem Lett, 2001,11:2229 - 2234. 被引量:1
  • 9Hogberg M, Sahlberg B, Engelhardt P, et al. Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. synthesis and further structure-activity relationship studies of PETT analogues [ J ]. J Med Chem, 1999,42(20) :4150-4160. 被引量:1
  • 10Esnouf RM, Stuart DI, De Clercq E, et al. Models which explain the inhibition of reverse transcriptase by HIV-1-specific ( thio ) carboxanilide derivatives [ J ].Biochem Biophys Commun, 1997,234(2) :458 -464. 被引量:1

共引文献26

同被引文献19

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部